Able Laboratories, Inc. Holds Auction for Its Assets
2005年11月3日 - 4:53AM
ビジネスワイヤ(英語)
Able Laboratories, Inc. (NASDAQ:ABRXQ) announced that it held an
auction of its assets on November 1, 2005 to solicit higher and
better bids than the bid reflected in the asset purchase agreement
entered into on October 19, 2005. At the conclusion of the auction,
the company entered into an asset purchase agreement dated November
1, 2005 with the winning bidder at the auction. The US Bankruptcy
Court for the District of New Jersey, Trenton Division has
scheduled a final hearing to consider the approval of the company's
sale of its assets and the assumption and assignment of contracts
under sections 363 and 365 of the Bankruptcy Code for November 7,
2005. Further information on the company may be found on the
company's web site, www.ablelabs.com. This release contains
statements that are forward-looking within the meaning of
applicable federal securities laws and are based upon the company's
current expectations and assumptions. You should not place undue
reliance on those statements because they speak only as of the date
of this release. Forward-looking statements include information
concerning the company's future operations, if any. These
statements often include words such as "expect," "plan," "believe,"
"anticipate," "intend," "estimate" or similar expressions. As you
read and consider this release, you should understand that these
statements are not guarantees of performance or results. They
involve risks, uncertainties and assumptions. Although the company
believes that these forward-looking statements are based on
reasonable assumptions, you should be aware that many factors could
affect actual results, which could differ materially from the
forward-looking statements. These factors include, but are not
limited to, uncertainty regarding the company's ability to
consummate a sale of its assets in a timely manner and to develop
and consummate one or more plans of reorganization; uncertainty
regarding court approval of the motions made by the company from
time to time; risks associated with third parties seeking and
obtaining court approval to terminate or shorten the exclusivity
period for the company to propose and confirm one or more plans of
reorganization or to appoint a chapter 11 trustee or convert the
bankruptcy case to a chapter 7 case; the company's ability to
continue as a going concern; the ultimate effect on the company of
the pending inspectional observations from the FDA to the company;
and the uncertainty relating to the ability of the company to
recommence manufacturing operations, if any, and various other
factors beyond the company's control. All future written and oral
forward-looking statements made by the company or persons acting on
the company's behalf are expressly qualified in their entirety by
the cautionary statements contained or referred to above. Except
for the company's ongoing obligations to disclose material
information as required by the federal securities laws, we do not
have any obligation or intention to release publicly any revisions
to any forward-looking statements to reflect events or
circumstances in the future or to reflect the occurrence of
unanticipated events.
Able Labs (NASDAQ:ABRXQ)
過去 株価チャート
から 8 2024 まで 9 2024
Able Labs (NASDAQ:ABRXQ)
過去 株価チャート
から 9 2023 まで 9 2024
Real-Time news about Able Laboratories (MM) (ナスダック市場): 0 recent articles
その他のAble Laboratories, Inc.ニュース記事